SCHEMBL27914045

SCHEMBL27914045

CC(C)CN(C)C(=O)c1cc(C(=O)N(Cc2ccc(-c3ccccc3)cc2)NCC(O)C(=O)O)[nH]n1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 18/20 0.62
▸ ITK Q08881 1/20 0.40
▸ ACR P10323 1/20 0.40
▸ ACE P12821 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28023724 0.90 MME (0.51) MME
SCHEMBL9938210 0.87 MME (0.64) MME
SCHEMBL16458038 0.87 MME (0.51) MME
SCHEMBL16458036 0.87 MME (0.51) MME
SCHEMBL9935381 0.82 MME (0.62) MMEACE
SCHEMBL9942293 0.82 MME (0.62) MMEACE
SCHEMBL27913953 0.82 MME (0.58) MMEACR
SCHEMBL27932205 0.82 MME (0.60) MME
SCHEMBL27932191 0.81 MME (0.45) MME
SCHEMBL27932188 0.81 MME (0.60) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103261168-B Enkephalinase inhibitor THERAVANCE BIOPHARMA R&D IP, LLC (US) 2015-08-05 — — CN disclosed
CN-103261168-A Enkephalinase inhibitors THERAVANCE INC 2013-08-21 — — CN disclosed
Send feedback